Kemstro

   
Google
 
Web NewDrugInformation.com

Kemstro


Drug - Kemstro
The trade name of the product as shown on the labeling.

Dosage - TABLET, ORALLY DISINTEGRATING; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Baclofen
Multiple ingredients are in alphabetical order.

Strength - 10MG
The potency of the active ingredient(s), Baclofen. May repeat for multiple part products.

Applicant - SCHWARZ PHARMA
The firm name holding legal responsibility for Kemstro. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021589
The FDA assigned number to Kemstro. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Kemstro. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Oct 30, 2003
The date Kemstro was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Kemstro. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Kemstro is in. Format is RX, OTC, DISCN.

Applicant Full Name - Schwarz Pharma Inc
The full name of the firm holding legal responsibility for the new application of Kemstro.

Kemstro